BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22321037)

  • 1. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.
    Cheon YK; Lee TY; Lee SM; Yoon JY; Shim CS
    HPB (Oxford); 2012 Mar; 14(3):185-93. PubMed ID: 22321037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.
    Lee TY; Cheon YK; Shim CS; Cho YD
    World J Gastroenterol; 2012 Oct; 18(39):5589-94. PubMed ID: 23112552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
    Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
    Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage].
    Cheon YK; Cho YD; Baek SH; Cha SW; Moon JH; Kim YS; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Gastroenterol; 2004 Nov; 44(5):280-7. PubMed ID: 15564808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.
    Gerhardt T; Rings D; Höblinger A; Heller J; Sauerbruch T; Schepke M
    Z Gastroenterol; 2010 Jan; 48(1):28-32. PubMed ID: 20072993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma.
    Höblinger A; Gerhardt T; Gonzalez-Carmona MA; Hüneburg R; Sauerbruch T; Schmitz V
    Eur J Med Res; 2011 Sep; 16(9):391-5. PubMed ID: 22024438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
    Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma.
    Hong MJ; Cheon YK; Lee EJ; Lee TY; Shim CS
    Gut Liver; 2014 May; 8(3):318-23. PubMed ID: 24827630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis.
    Moole H; Tathireddy H; Dharmapuri S; Moole V; Boddireddy R; Yedama P; Dharmapuri S; Uppu A; Bondalapati N; Duvvuri A
    World J Gastroenterol; 2017 Feb; 23(7):1278-1288. PubMed ID: 28275308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy in cholangiocarcinoma.
    Kahaleh M
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S44-7. PubMed ID: 23055215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic Therapy in Patients with Advanced Hilar Cholangiocarcinoma: Percutaneous Cholangioscopic Versus Peroral Transpapillary Approach.
    Lee TY; Cheon YK; Shim CS
    Photomed Laser Surg; 2016 Apr; 34(4):150-6. PubMed ID: 26982507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
    Harewood GC; Baron TH; Rumalla A; Wang KK; Gores GJ; Stadheim LM; de Groen PC
    J Gastroenterol Hepatol; 2005 Mar; 20(3):415-20. PubMed ID: 15740486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
    Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
    Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma.
    Wentrup R; Winkelmann N; Mitroshkin A; Prager M; Voderholzer W; Schachschal G; Jürgensen C; Büning C
    Gut Liver; 2016 May; 10(3):470-5. PubMed ID: 26814610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.
    Dumoulin FL; Gerhardt T; Fuchs S; Scheurlen C; Neubrand M; Layer G; Sauerbruch T
    Gastrointest Endosc; 2003 Jun; 57(7):860-7. PubMed ID: 12776033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients.
    Liberato MJ; Canena JM
    BMC Gastroenterol; 2012 Aug; 12():103. PubMed ID: 22873816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma.
    Li Z; Jiang X; Xiao H; Chen S; Zhu W; Lu H; Cao L; Xue P; Li H; Zhang D
    Surg Endosc; 2021 Oct; 35(10):5655-5664. PubMed ID: 33104917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
    Prasad GA; Wang KK; Baron TH; Buttar NS; Wongkeesong LM; Roberts LR; LeRoy AJ; Lutzke LS; Borkenhagen LS
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):743-8. PubMed ID: 17545000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.